# Effect of Low-fat Diet on the Pharmacokinetics of Pyrotinib in Healthy Participants

> **NCT04315493** · PHASE1 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 16 (estimated)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** pyrotinib maleate fasted in P1, low-fat diet in P2
- **DRUG:** pyrotinib maleate low-fat diet in P1, fasted in P2

## Key facts

- **NCT ID:** NCT04315493
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03
- **Primary completion:** 2020-03
- **Final completion:** 2020-04
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2020-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04315493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04315493, "Effect of Low-fat Diet on the Pharmacokinetics of Pyrotinib in Healthy Participants". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04315493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*